Related Experiment Video
Updated: Mar 28, 2026

Visualization of DNA Repair Proteins Interaction by Immunofluorescence
Published on: June 26, 2020
SLFN11 inhibits checkpoint maintenance and homologous recombination repair
Yanhua Mu1, Jiangman Lou1, Mrinal Srivastava2
1Life Sciences Institute and Innovation Center for Cell Signaling Network, Zhejiang University, Hangzhou Zhejiang, China.
Abstract:
High expression levels of SLFN11 correlate with the sensitivity of human cancer cells to DNA-damaging agents. However, little is known about the underlying mechanism. Here, we show that SLFN11 interacts directly with RPA1 and is recruited to sites of DNA damage in an RPA1-dependent manner. Furthermore, we establish that SLFN11 inhibits checkpoint maintenance and homologous recombination repair by promoting the destabilization of the RPA-ssDNA complex, thereby sensitizing cancer cell lines expressing high endogenous levels of SLFN11 to DNA-damaging agents. Finally, we demonstrate that the RPA1-binding ability of SLFN11 is required for its function in the DNA damage response. Our findings not only provide novel insight into the molecular mechanisms underlying the drug sensitivity of cancer cell lines expressing SLFN11 at high levels, but also suggest that SLFN11 expression can serve as a biomarker to predict responses to DNA-damaging therapeutic agents.
Insights
High SLFN11 expression sensitizes cancer cells to DNA-damaging agents by disrupting DNA repair. This mechanism involves SLFN11 interacting with RPA1, inhibiting repair, and highlighting SLFN11 as a predictive biomarker.
Area of Science:
- Molecular Biology
- Cancer Research
- DNA Damage Response
Background:
- High expression of SLFN11 correlates with sensitivity in human cancer cells treated with DNA-damaging agents.
- The precise molecular mechanisms driving this sensitivity remain largely unelucidated.
Purpose of the Study:
- To elucidate the mechanism by which SLFN11 confers sensitivity to DNA-damaging agents.
- To investigate the role of SLFN11 in DNA damage response pathways.
Main Methods:
- Investigated the interaction between SLFN11 and RPA1 using co-immunoprecipitation.
- Assessed recruitment of SLFN11 to DNA damage sites via immunofluorescence.
- Evaluated the impact of SLFN11 on DNA repair pathways, including checkpoint maintenance and homologous recombination.
- Utilized cancer cell lines with varying endogenous SLFN11 levels.
Main Results:
- SLFN11 directly interacts with RPA1 and is recruited to DNA damage sites in an RPA1-dependent manner.
- SLFN11 inhibits checkpoint maintenance and homologous recombination repair by destabilizing the RPA-ssDNA complex.
- Cancer cell lines with high SLFN11 expression are sensitized to DNA-damaging agents.
- The RPA1-binding capability of SLFN11 is essential for its function in DNA damage response.
Conclusions:
- SLFN11 sensitizes cancer cells to DNA-damaging agents by interfering with DNA repair mechanisms through RPA1 interaction.
- SLFN11 expression levels can potentially serve as a predictive biomarker for therapeutic response to DNA-damaging agents.
More Related Videos
Related Concept Videos
Restarting Stalled Replication Forks
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Homologous Recombination
Homologous Recombination
The DNA Replication Fork

